Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001702626-19-000004)

Filing Details

Accession Number:: 0001702626-19-000004
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-25 11:04:42
Reporting Period:: 2019-06-21

Accepted Time:: 2019-06-25 11:04:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
946644	Hemispherx Biopharma Inc	HEB	Biological Products, (No Disgnostic Substances) (2836)	520845822

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1583701	W. Peter Iii Rodino	2117 Sw Highway 484 Ocala FL 34473	Dir Govt Relations/Sectry	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-06-21	8,695	$4.03	12,590	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Previous Balance of the amount of securities owned was divided by 44 due to the 44/1 stock split which occurred on June 11, 2019.